GSK plc GSK-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 10:39 AM BST
1,302.40quote price arrow down-3.40 (-0.26%)
52 week range
1,280.92 - 1,842.76
Loading...
  • Open1,290.00
  • Day High1,304.20
  • Day Low1,287.20
  • Prev Close1,305.80
  • 52 Week High1,842.76
  • 52 Week High Date07/06/22
  • 52 Week Low1,280.92
  • 52 Week Low Date09/22/22

Key Stats

  • Market Cap47,157.54M
  • Shares Out3,253.86M
  • 10 Day Average Volume14.41M
  • Dividend93.75
  • Dividend Yield7.20%
  • Beta0.52
  • YTD % Change-35.16

KEY STATS

  • Open1,290.00
  • Day High1,304.20
  • Day Low1,287.20
  • Prev Close1,305.80
  • 52 Week High1,842.76
  • 52 Week High Date07/06/22
  • 52 Week Low1,280.92
  • 52 Week Low Date09/22/22
  • Market Cap47,157.54M
  • Shares Out3,253.86M
  • 10 Day Average Volume14.41M
  • Dividend93.75
  • Dividend Yield7.20%
  • Beta0.52
  • YTD % Change-35.16

RATIOS/PROFITABILITY

  • EPS (TTM)110.42
  • P/E (TTM)11.79
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/18/2022
  • Div Amount16.25
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
GSK plc is a global biopharma company. The Company makes vaccines and specialty medicines to prevent and treat disease. Its segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed a new monoclonal antibody treatment for COVID-19. Its product areas include vaccines, specialty medicines, and general medicines. Its vaccine portfolio...
Jonathan Symonds CBE
Independent Non-Executive Chairman of the Board
Emma Walmsley
Chief Executive Officer, Executive Director
Iain Mackay
Chief Financial Officer, Executive Director
Address
980 Great West Road
Brentford
TW8 9GS
United Kingdom